Thromb Haemost 1995; 74(04): 1204
DOI: 10.1055/s-0038-1649909
Letter To The Editor
Schattauer GmbH Stuttgart

Complement Activation and Tissue Factor Expression on the Feto-Placental Allograft

H M Cheng
Department of Physiology, University of Malaysia, Kuala Lumpur, Malaysia
› Author Affiliations
Further Information

Publication History

Received 19 May 1994

Accepted after revision 12 July 1995

Publication Date:
09 July 2018 (online)

 
  • References

  • 1 Key NS. Towards an understanding of the pathophysiological mechanism of thrombosis in the antiphospholipid antibody syndrome. J Lab Clin Med 1995; 125: 16-19
  • 2 Cheng HM. Immunophysiology of Antiphospholipid Antibodies. San Antonio, Texas, USA: R. G. Landes Biomedical Publishers; 1994
  • 3 Reverdiau P, Jarousseau AC, Thibault G, Khalfoun B, Watler H, Lebranchu Y, Bardos P, Gruel Y. Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture. Thromb Haemost 1995; 73: 49-54
  • 4 Purcell DF J, Mckenzie IF C, Lublin DM, Johnson PM, Atkinson JP, Oglesby TJ, Deacon NJ. The human cell surface glycoprotein HuLy-m5, membrane cofactor protein (MCP) of the complement system and trophoblast leucocyte common (TLX) antigen are CD46. Immunol 1990; 70: 155-161
  • 5 Cheng HM, Johnson PM. A description of human placental syncytiotrophoblast membrane glycosphingolipids. Placenta 1985; 6: 229-238
  • 6 Session A, Horowitz A. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim Biophys Acta 1983; 728: 103-111
  • 7 Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137: 1532-1537
  • 8 Carson SD, Johnson DR. Consecutive enzyme cascades – Complement activation at the cell surface triggers increased tissue factor activity. Blood 1990; 76: 361-367
  • 9 Roubey RA S. Autoantibodies to phospholipid-binding plasma proteins - A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 1994; 84: 2854-2867
  • 10 Chamley LW, Pattison NS, Mckay EJ. Elution of anticardiolipin antibodies and their cofactor β2-glycoprotein I from placentae of patients with poor obstetrics history. J Reprod Immunol 1994; 25: 209-220
  • 11 McIntyre JA. Immune recognition at the maternal-fetal inerface: overview. Am J Reprod Immunol 1992; 28: 127-131
  • 12 La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden D, Lojacono A, Morassi L, Brocchi E, Del Papa N, Gharavi A, Sammaritano L, Lockshin M. β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid antibody syndrome. J Rheumatol 1994; 21: 1684-1693
  • 13 Walker FJ. Does β2-glycoprotein I inhibit the interaction between protein S and C4b binding protein. Thromb Haemost 1993; 69: 930 A
  • 14 Martinuzzo ME, Forastiero RR, Carreras LO. Anti β2-glycoprotein I antibodies – Detection and association with thrombosis. Br J Haematol 1995; 82: 397-402
  • 15 Johnson PM, Cheng HM, Stevens VC, Matangkasombut P. Antibody reactivity against trophoblast and trophoblast products. J Reprod Immunol 1985; 8: 347-352
  • 16 McCrae KR, DeMichele AM, Pandhi P, Balsai MJ, Samuels P, Graham C, Lala PK, Cines DB. Detection of antitrophoblast antibody in sera of patients with anticardiolipin antibody and fetal loss. Blood 1993; 82: 2730-2741